Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. - Wikidata - awgldk - TriplyDB

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

http://www.wikidata.org/entity/Q34005000

about

Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.CD4+ Recent Thymic Emigrants Are Recruited into Granulomas during Leishmania donovani Infection but Have Limited Capacity for Cytokine Production Regulation of immunity during visceral Leishmania infection Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis.Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.Clinical and experimental advances in treatment of visceral leishmaniasis.Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.Tissue granuloma structure-function in experimental visceral leishmaniasis.Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis Let off the leash: kala-azar following the use of tumour necrosis factor antibodies Balancing immunity and pathology in visceral leishmaniasis.Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen Immunobiology of visceral leishmaniasis.Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages.Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18 Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.The immunopathology of experimental visceral leishmaniasis.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Functional complexity of the Leishmania granuloma and the potential of in silico modeling.Immune responses during cutaneous and visceral leishmaniasis.Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites.Leishmania donovani influenced cytokines and Toll-like receptors expression among Sudanese visceral leishmaniasis patients.

P2860

Q24538777-95D51790-185C-43BE-AF4A-4A10A63AC26F Q27321353-1172AEAA-C538-445B-A6B1-5F951571B27C Q28066034-B918D013-0317-4C6C-A0E7-D9E370303949 Q28344860-38F7D62F-9A01-48F8-8620-664B50153BE4 Q31036509-48E5F468-C6FE-429E-945F-18B454F76543 Q33370533-CCFE4377-6B73-4EA6-B9F6-957EB03E8F0D Q33883498-B2C01722-8E9B-4F70-915B-022D79E6DC0A Q33982648-85CFD493-B374-4969-8FB6-503ED5EFCFBA Q34181985-290B4C91-0E83-4604-8C14-B974C99E91C1 Q34211871-31C6DF17-B89E-4F15-9202-7715AE5C2BC6 Q34310410-D46AEA78-3918-44DB-9B83-42DD4699032E Q34434760-4871E4BF-2314-4503-B968-1F11679FCE4D Q34510505-52F6518D-E89E-42ED-AB18-D6B602073A7D Q34521577-45BDC249-44A6-4737-99A9-0544C7E6A385 Q34533118-3C062B12-71E0-4B80-900A-CCAC58E52B33 Q34587432-23E4D1B1-A5C5-417B-9699-93E9DE524016 Q34637852-8C02A925-98F6-4E35-81B4-9813EBD598B5 Q34641680-BD2D3F17-BDD2-46AA-9277-6B16B782674A Q34648790-09490947-B567-4743-812A-DB7005B1D646 Q34721430-6A81239F-7972-4D81-AEE1-69808B45CD2D Q34721449-FA98F2F9-E2E9-4CE4-B90A-4B50874FFE83 Q34955529-6485E7FF-FC64-4BFB-9E75-BF7DC9CE33E4 Q35103595-F738EE4D-D535-4028-9DE1-8E8A6EE07EF2 Q35138682-E939E927-7B1A-4A41-B6CC-32971806C484 Q35747613-91885BA1-6D7F-43B3-A920-145AC05B4175 Q35809113-46815901-CA91-458E-920F-4EA4EE86E89D Q35884243-08D14BC1-FFB3-4613-BE40-FE3C28AE9A1C Q35893711-671455C7-6DEA-4F1C-B451-733C10C65999 Q35947234-5176533E-A54D-43F7-B605-EAE1DACDB791 Q36141819-996211A7-4DFC-4851-ABA5-C7C11D7BBF2B Q36376714-CADC838D-8D0A-4BF9-8BE4-812FDA389FBC Q36868265-D24233DA-F18D-4E8C-9E92-F1388E0D2DFA Q36970905-737CFBFE-C054-449D-89A9-3F237203E124 Q37388291-BB77ACCB-8DE0-4D2F-B355-72C4E8C72805 Q37546954-4CE44B80-465D-4BE7-B053-8A8D031CEAFD Q38040818-AB86B986-3916-4EF3-964A-9627EE72B006 Q38083024-7FFA9E56-4A1A-423C-9460-9B2883A339A6 Q38235268-106B814B-E685-4CCE-87A0-8E1025162FBD Q38342966-7E9CC42A-48BC-4D31-AABA-46C48F8B63D2 Q38873769-AE15A82B-336E-449F-96B2-4E0922E8FBFB

P2860

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

http://www.wikidata.org/entity/Q34005000

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@ast

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@en

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@nl

type

label

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@ast

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@en

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@nl

prefLabel

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@ast

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@en

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@nl

P1433

Q34005000-BA7FF39F-0DF7-4058-AEBD-22A91FC4A5AD

P1476

Q34005000-A2AB8201-267D-4FBE-BC0B-973330CB620C

P2093

Q34005000-1EB2DA70-CF5A-4FAD-BEC9-8F81D41A3065

Q34005000-30454190-67ED-477C-A780-A88A77A0D798

Q34005000-846203B0-A3FB-4460-9E68-167EF01CC807

Q34005000-A409B07A-C764-40F1-B5BC-1E8FE18099D3

P2860

Q34005000-009E584E-BA8A-43A9-891C-E31066798553

Q34005000-04F9E2DA-77F6-4761-9BE4-19ECF0692EF7

Q34005000-0AA4210B-D29F-4206-A6EE-197AAA8ACFD8

Q34005000-0F68D796-A261-42CE-885A-D40615785A23

Q34005000-14F1E202-27D4-4EF8-BA26-6869C5BEA90E

Q34005000-15F936C9-A97D-4068-877E-20F6DF8637A2

Q34005000-23B5D456-2446-4D06-881C-FCA8441D3505

Q34005000-2C90F007-DB80-4999-BC9B-22AFD6C34D7E

Q34005000-2E4CC13D-2658-43CB-A6B5-BF29A42D45E8

Q34005000-2F24104B-ADB1-480E-8CDC-60B66BBEC732

P304

Q34005000-681AE7FA-5155-4722-BEA7-2191D29CDDED

P31

Q34005000-AD799440-198B-44D1-B987-34C922071927

P356

Q34005000-D110338D-4E4F-4523-91F7-AD0324A79E8A

P407

Q34005000-188F9191-B7FB-40F2-8B92-02AAA22ED644

P433

Q34005000-7414CEFA-2B80-41C3-A7E1-9C07C91D7596

P478

Q34005000-2451F551-C434-4757-8EB1-6F344B580877

P50

Q34005000-D6ED145F-2E14-43C0-82F8-A94CA5B094CF

P577

Q34005000-5EF42BD3-221C-4384-BCD0-2D9F417BE277

P698

Q34005000-6B9EA18A-3C16-49EA-9F7A-D60E26E543F0

P921

Q34005000-179494D4-9264-4B4D-A32F-B1B98571D757

P932

Q34005000-FF6A3423-8AF2-4688-8D8B-97BDE29E2AB4

P356

IAI.68.11.6289-6293.2000

P1433

Infection and Immunity

P1476

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.

@en

P2093

A Jungbluth

http://www.w3.org/2001/XMLSchema#string

C Montelibano

http://www.w3.org/2001/XMLSchema#string

H W Murray

http://www.w3.org/2001/XMLSchema#string

M W Marino

http://www.w3.org/2001/XMLSchema#string

P2860

Trial of oral miltefosine for visceral leishmaniasis

Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

Characterization of tumor necrosis factor-deficient mice

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium

Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.

The pathophysiology of tumor necrosis factors.

Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

P304

6289-6293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.68.11.6289-6293.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11035737

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis

P932

97711

http://www.w3.org/2001/XMLSchema#string